Perrigo Ordinary Shares reported $349M in Gross Profit on Sales for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Gross Profit On Sales Change
Abbott ABT:US $ 6505M 1225M
Aphria Inc APH:CN C$ -7278000 20.68M
Bayer BAYN:GR 6.31B 1.32B
Bristol Myers Squibb BMY:US $ 9333M 81M
Catalent CTLT:US $ 439.3M 73.7M
Coherus Biosciences CHRS:US $ 70.95M 4.58M
Corcept Therapeutics CORT:US $ 90.2M 12.04M
Dr.Reddys Laboratories DRRD:IN 32.43B 163M
Eli Lilly And LLY:US $ 5342M 555.1M
Endo International Ordinary Shares ENDP:US $ 400.4M 27.52M
Flexion Therapeutics FLXN:US $ 23.2M 4.69M
Gw Pharmaceuticals GWPH:US $ 140.66M 2.86M
Horizon Pharma HZNP:US $ 631.55M 389.52M
JAZZ PHA JAZZ:US $ 632.62M 65.22M
Johnson & Johnson JNJ:US $ 16088M 343M
Lannett LCI:US $ 22.66M 3.8M
Merk MRK:US $ 8360M 265M
Pacira Pharmaceuticals PCRX:US $ 100.34M 12.66M
Perrigo Ordinary Shares PRGO:US $ 349M 19.4M
Pfizer PFE:US $ 11985M 1575M
Phibro Animal Health PAHC:US $ 69.83M 0.66M
Prestige Brands PBH:US $ 159.01M 21.96M
Supernus Pharmaceuticals SUPN:US $ 116.3M 0.32M
Teva Pharmaceutical TEVA:IT 1.9B 25M
Xeris Pharmaceuticals Inc XERS:US $ 5.52M 846K
Zoetis ZTS:US $ 1384M 56M